Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The mutational landscape and prognostic indicators of pseudomyxoma peritonei originating from the ovary.

International journal of cancer - 15 Apr 2021

Wang Bing, Yao Jianfei, Ma Ruiqing, Liu Danni, Lu Yiyan, Shi Guanjun, An Lubiao, Xia Ao, Chen Feng, Pang Shaojun, Zhai Xichao, Liu Guifeng, Chen Shifu, Xu Mingyan, Song Lele, Xu Hongbin

Abstract excerpt

Pseudomyxoma peritonei (PMP) is a rare disorder with unique pathological and genetic changes. Although several studies have reported the clinical features and mutational changes of PMP that originates from the appendix, few studies on PMP originating from the ovary have been reported due to its extreme rarity. In order to characterize the somatic mutational landscape and to investigate the prognosis predicting...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ataxia Telangiectasia Mutated Proteins
Share to Exome Sequencing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Histone-Lysine N-Methyltransferase

Share to Kaplan-Meier Estimate

Share to Peritoneal Neoplasms

Share to Retinoblastoma Binding Proteins

Share to Ubiquitin-Protein Ligases

Source

Identifiers

PMID: 33403690
DOI: 10.1002/ijc.33460

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The mutational landscape and prognostic indicators of pseudomyxoma peritonei originating from the ovary.PMID 33403690Read ↗

Appendix-derived Pseudomyxoma Peritonei (PMP): Molecular Profiling Toward Treatment of a Rare Malignancy.Semantic proximity Read ↗

Whole-Exome Sequencing Identifies Mutation Profile and Mutation Signature-Based Clustering Associated with Prognosis in Appendiceal Pseudomyxoma Peritonei.Semantic proximity Read ↗

Targeted Genetic Sequencing Analysis of 223 Cases of Pseudomyxoma Peritonei Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Shows Survival Related to GNAS and KRAS Status.Semantic proximity Read ↗

Genomic profile of pseudomyxoma peritonei analyzed using next-generation sequencing and immunohistochemistry.Semantic proximity Read ↗

Molecular profiles of high-grade and low-grade pseudomyxoma peritonei.Semantic proximity Read ↗

A case of Pseudomyxoma Peritonei of an unexpected origin.Semantic proximity Read ↗

Rare Occurrence of Pseudomyxoma Peritonei (PMP) Syndrome Arising from a Malignant Transformed Ovarian Primary Mature Cystic Teratoma Treated by Cytoreductive Surgery and HIPEC: A Case ReportSemantic proximity Read ↗

A New Molecular (P)Layer in Pseudomyxoma Peritonei: The Splicing Machinery is Dysregulated and Linked to Low SurvivalSemantic proximity Read ↗

Pathological prognostic factors of pseudomyxoma peritonei: comprehensive clinicopathological analysis of 155 cases.Semantic proximity Read ↗

Precision Oncology and Systemic Targeted Therapy in Pseudomyxoma Peritonei.Semantic proximity Read ↗

Analysis of Mutation and Loss of Heterozygosity by Whole-Exome Sequencing Yields Insights into Pseudomyxoma Peritonei.Semantic proximity Read ↗

Distinct cell states define the developmental trajectories of mucinous appendiceal neoplasms towards pseudomyxoma metastasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.